Search

for
Search:

Glossary Patient-Reported Outcome Measures

tools for patients to report their health and treatment outcomes

Patient-Reported Outcome Measures (PROMs) are tools used to gather information directly from patients about their health status, quality of life, and the effectiveness of treatments from their perspective. These measures are crucial in both clinical practice and research as they provide insights into how patients feel and function, which can help guide treatment decisions and improve healthcare outcomes.

Related Terms

Research

5 / 1000+ results

research Alopecia Areata–Specific Patient-Reported Outcome Measures

2 citations , March 2025 in “JAMA Dermatology”

This review evaluates the quality of alopecia areata-specific patient-reported outcome measures and suggests that more high-quality validation studies are needed to enhance their reliability and validity.

research Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q

2 citations , July 2024 in “Journal of Cosmetic Dermatology”

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

research An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population

1 citations , January 2025 in “JEADV Clinical Practice”

This study reported that the AAPPO tool effectively distinguishes between patients with alopecia areata based on scalp hair loss severity, whereas the EQ‐5D‐5L may underestimate the specific disease burden, particularly in psychological and social aspects.

research P151 A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: patient-reported outcome measures

June 2026 in “British Journal of Dermatology”

In this real-world study, 27% of alopecia areata patients treated with ritlecitinib achieved a target SALT score, a result consistent with clinical trial findings, highlighting the value of patient-reported outcomes in understanding treatment impact beyond traditional measures.

research PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA

May 2011 in “Value in Health”

This review assessed patient-reported outcome measures for alopecia treatments but found that none met current FDA guidelines; however, some could potentially be adapted for more comprehensive use.

View more "patient-reported outcome measures" in research →

Community Join

5 / 1000+ results

community Could creatine trigger faster hairloss?

29 upvotes 2 years ago

Creatine is reported by many to increase hair loss, though no scientific evidence supports this. Some use finasteride and minoxidil to manage hair loss, while others avoid creatine due to personal experiences.

community Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study

93 upvotes 1 month ago

Oral dutasteride 0.5 mg combined with oral minoxidil 2.5 mg is highly effective for male androgenetic alopecia, showing over 60% improvement and 98% stabilization at 6 months, with low adverse event rates. Patients with severe baseline conditions respond better and faster to this treatment.

community Be careful when switching from Finasteride to Dutasteride because for more efficacy.

in Finasteride/Dutasteride 13 upvotes 1 year ago

Switching from finasteride to dutasteride may be more effective for hair regrowth due to dutasteride's stronger enzyme inhibition, but combining both drugs could enhance results. Some users report better outcomes with dutasteride, while others recommend a gradual transition to prevent potential hair loss.

community DHT is NOT very important for adults, is it?

124 upvotes 4 months ago

A user experienced negative side effects, including low libido and lack of motivation, after using finasteride for hair loss and felt better after stopping it. Others shared similar experiences with finasteride and dutasteride, while some reported no side effects, showing varied individual responses.

community Veradermics VDPHL01 Topline Results for Extended-Release Oral Minoxidil

75 upvotes 4 months ago

Extended-release oral minoxidil (VDPHL01) shows promising results for hair growth with improved safety, achieving significant hair count increases and minimal side effects compared to placebo. The treatment is designed to maintain effective concentrations while reducing side effects, making it a safer option for those who cannot tolerate standard minoxidil.

View more "patient-reported outcome measures" in community →

Learn

4 / 801 results

learn Saw Palmetto

a natural and far less effective alternative to Finasteride

learn Dexpanthenol

precursor of vitamin B5 with hair stimulating effects

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

learn Neem Oil

natural substance from Neem tree with medicinal and pesticidal properties

View more "patient-reported outcome measures" in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →